|
2024
|
G/S
|
Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the tr... |
|
2023
|
Invention
|
Oral formulations of kappa opioid receptor agonists.
The invention provides formulations for ora... |
|
|
Invention
|
Oligosaccharide formulations of kappa opioid receptor agonists.
The invention provides formulati... |
|
2022
|
G/S
|
Pharmaceutical preparations for the treatment of pruritus; pharmaceutical preparations for the tr... |
|
|
Invention
|
Atopic dermatitis therapy with kappa opioid receptor agonist as adjunct to topical corticosteroid... |
|
2021
|
Invention
|
Kappa opioid receptor agonist-therapeutic antigen binding protein conjugate (ktac) compounds.
Co... |
|
|
Invention
|
Kappa opioid receptor agonist-therapeutic antigen binding protein conjugate (ktac) compounds. Con... |
|
|
Invention
|
Oral formulations of kappa opioid receptor agonists. The invention provides formulations for oral... |
|
|
G/S
|
Pharmaceutical research and development |
|
|
Invention
|
Oligosaccharide formulations of kappa opioid receptor agonists. The invention provides formulatio... |
|
2017
|
Invention
|
Peripheral kappa opioid receptor agonists for uremic pruritus in dialysis patients.
The inventio... |
|
2016
|
Invention
|
Uses of kappa opioid synthetic peptide amides.
The invention relates to methods of use of synthe... |
|
2015
|
Invention
|
Peripheral kappa opioid receptor agonists for hard tissue pain.
A method for preventing, inhibit... |
|
|
Invention
|
Peripheral kappa opioid receptor agonists for hard tissue pain. A method for preventing, inhibiti... |
|
2014
|
Invention
|
Peripheral kappa opioid receptor agonists for preventing, inhibiting or treating nausea and vomit... |
|
2013
|
Invention
|
Method for elevating prolactin in mammals.
Methods for elevating and stabilizing prolactin level... |
|
|
Invention
|
Peripheral kappa receptor agonists for reducing pain and inflammation.
A method of treating of a... |
|
|
Invention
|
Peripheral kappa receptor agonists for reducing pain and inflammation. A method of treating of a ... |
|
2010
|
Invention
|
Uses of substituted imidazoheterocycles. The present invention provides a method of prophylaxis, ... |
|
|
Invention
|
Bicyclic pyrazolo-heterocycles. The present invention provides substituted pyrazolo-heterocycles ... |
|
2009
|
Invention
|
Substituted imidazoheterocycle derivatives. The present invention provides substituted imidazohet... |
|
|
Invention
|
Azabenzimidazolones.
Compounds are provided having the general structure of formula I:
Compoun... |
|
|
Invention
|
Azabenzimidazolones. Compounds are provided having the general structure of formula I: In formula... |
|
|
Invention
|
Substituted pyridoxazines. The invention provides compounds having the structure of formula I,
4... |
|
|
Invention
|
Substituted pyridoxazines. The invention provides compounds having the structure of formula I, an... |
|
|
Invention
|
Amide or thioamide derivatives and their use in the treatment of pain.
The present invention rel... |
|
2008
|
Invention
|
Substituted imidazoheterocycles. The present invention provides substituted imidazoheterocyclic c... |
|
|
Invention
|
Gossypium hirsutum cotton. Methods for distinguishing between cotton species by analyzing a sampl... |
|
|
Invention
|
Benzo-fused heterocycles. The present invention provides benzo-fused heterocyclic compounds havin... |
|
|
Invention
|
Substituted imidazo[1,5-a][1,4]diazepines and imidazo[1,5-a]pyrazines as cannabinoid receptor ago... |
|
|
Invention
|
Bridged phenanthridines. Bridged phenanthridine compounds having the structure of formula I or of... |
|
|
Invention
|
Bridged phenanthridines.
Bridged phenanthridine compounds having the structure of formula I or o... |
|
2007
|
Invention
|
Tetrahydroquinolinones, tetrahydronaphthyridones and derivatives thereof. Tetrahydroquinolinone a... |
|
|
Invention
|
Tetrahydroquinilinones, tetrahydronaphthyridones and derivatives thereof.
Tetrahydroquinolinone ... |
|
|
Invention
|
Synthetic peptide amides and dimers thereof. The invention relates to synthetic peptide amide lig... |
|
|
Invention
|
Synthetic peptide amides. The invention relates to synthetic peptide amide ligands of the kappa o... |
|
|
Invention
|
N-oxides of kappa receptor peptides.
Certain peptides which exhibit high selectivity for the kap... |
|
|
Invention
|
N-oxides of kappa opioid receptor peptides. Certain peptides which exhibit high selectivity for t... |
|
|
Invention
|
Method for elevating prolactin in mammals. Methods for elevating and stabilizing prolactin levels... |
|
2005
|
G/S
|
pharmaceutical development |
|
2004
|
Invention
|
Amide or thioamide derivatives and their use in the treatment of pain. The present invention rela... |
